Wall Street brokerages predict that Tivity Health Inc (NASDAQ:TVTY) will announce $152.59 million in sales for the current quarter, Zacks Investment Research reports. Six analysts have issued estimates for Tivity Health’s earnings. The highest sales estimate is $153.50 million and the lowest is $151.42 million. Tivity Health posted sales of $138.91 million in the same quarter last year, which suggests a positive year-over-year growth rate of 9.8%. The firm is scheduled to report its next earnings report on Thursday, October 25th.

According to Zacks, analysts expect that Tivity Health will report full-year sales of $611.68 million for the current fiscal year, with estimates ranging from $609.32 million to $615.60 million. For the next year, analysts anticipate that the firm will report sales of $656.44 million per share, with estimates ranging from $646.89 million to $668.80 million. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that follow Tivity Health.

Tivity Health (NASDAQ:TVTY) last issued its quarterly earnings results on Thursday, August 2nd. The company reported $0.53 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.53. Tivity Health had a net margin of 13.79% and a return on equity of 28.38%. The company had revenue of $151.90 million during the quarter, compared to the consensus estimate of $152.98 million. During the same quarter in the prior year, the firm posted $0.41 EPS. The firm’s quarterly revenue was up 9.4% on a year-over-year basis.

A number of brokerages have recently weighed in on TVTY. BidaskClub downgraded shares of Tivity Health from a “sell” rating to a “strong sell” rating in a report on Thursday. SunTrust Banks reaffirmed a “buy” rating and set a $46.00 price target on shares of Tivity Health in a report on Friday, August 3rd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $53.00 price target on shares of Tivity Health in a report on Monday, April 23rd. Piper Jaffray Companies reaffirmed a “buy” rating and set a $49.00 price target on shares of Tivity Health in a report on Tuesday, April 24th. Finally, Chardan Capital raised shares of Tivity Health from a “neutral” rating to a “buy” rating and set a $42.00 price target for the company in a report on Monday, June 4th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have given a buy rating to the stock. Tivity Health currently has an average rating of “Buy” and a consensus target price of $47.25.

Shares of Tivity Health stock opened at $32.85 on Friday. Tivity Health has a 1-year low of $29.95 and a 1-year high of $48.50. The company has a market cap of $1.35 billion, a PE ratio of 19.55, a PEG ratio of 1.43 and a beta of 0.46.

Institutional investors have recently modified their holdings of the company. Globeflex Capital L P increased its position in Tivity Health by 12.4% during the 2nd quarter. Globeflex Capital L P now owns 14,500 shares of the company’s stock worth $510,000 after purchasing an additional 1,600 shares in the last quarter. Prudential Financial Inc. increased its position in Tivity Health by 2.9% during the 1st quarter. Prudential Financial Inc. now owns 58,182 shares of the company’s stock worth $2,307,000 after purchasing an additional 1,630 shares in the last quarter. Rhumbline Advisers increased its position in Tivity Health by 2.0% during the 1st quarter. Rhumbline Advisers now owns 83,475 shares of the company’s stock worth $3,310,000 after purchasing an additional 1,650 shares in the last quarter. US Bancorp DE increased its position in Tivity Health by 6.2% during the 1st quarter. US Bancorp DE now owns 29,549 shares of the company’s stock worth $1,172,000 after purchasing an additional 1,726 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in Tivity Health by 0.6% during the 1st quarter. Principal Financial Group Inc. now owns 289,546 shares of the company’s stock worth $11,480,000 after purchasing an additional 1,790 shares in the last quarter.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

Read More: Fundamental Analysis – How It Helps Investors

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.